Quality of life in oncology and quality of life in course of molecularly targeted therapy in patients diagnosed with metastatic renal-cell carcinoma
Journal Title: OncoReview - Year 2011, Vol 1, Issue 4
Abstract
Introduction of molecularly targeted agents into clinical practice has led to marked progress in pharmacotherapy of advanced renal cell carcinoma. There have been six drugs of the therapeutic class registered to date. Further registration is expected next year. Targeted therapy proved to prolong time to disease progression of renal cell cancer. If administered sequentially they prolong overall survival as well. The treatment usually tends to last. The disease gains status of chronic illness. Molecular predictive factors are not available and decisions regarding specific therapeutic choices are based on clinical factors. Due to all aforementioned the toxicity profile and related quality of life should be of special interest. The article is the discussion of methodology of quality of life clinical trials, the data collection, data analysis and review of current knowledge regarding this issue in context of treatment of renal cell carcinoma based on molecularly targeted therapy.
Authors and Affiliations
Jakub Żołnierek, Piotr Wysocki
Keywords
Related Articles
- EP ID EP53129
- DOI -
- Views 229
- Downloads 0
Zaburzenia psychiczne u chorych na nowotwory - podejście kliniczne
Pacjent z chorobą nowotworową nie tylko mierzy się z chorobą pierwotną, ale także narażony jest na stany emocjonalne, które przy niesprzyjających warunkach i dużym obciążeniu mogą prowadzić do depresji, zwiększonego lęku...
Planning hormonal therapy in prostate cancer patients – expert view
In last decades prostate cancer became one of the most common cancers in the World, and one of the most common cancer death diagnosis. As a hormone-dependent entity for almost 70 years prostate cancer is treated with hor...
Acute coronary syndrome in patients with concomitant neoplastic disease and chemotherapy. Is clinical distinctness possible?
We present 2 cases of acute coronary syndrome in patients with concomitant neoplastic disease during chemotherapy. In both patients, we found unusual angiographic image which showed that despite the presence of very larg...
58-year-old woman with pancreatic neuroendocrine tumour
We reported a 58-year-old woman with tumor in the tail and body of pancreas measuring 70 mm in diameter who underwent distal pancreatectomy and splenectomy. Examination of a specimen of the pancreatic mass obtained histo...
Zasady postępowania diagnostyczno-terapeutycznego u chorych na nowotwory podścieliskowe przewodu pokarmowego (GIST) w 2010 roku
Nowotwory podścieliskowe przewodu pokarmowego (ang. gastrointestinal stromal tumors, GIST) są najczęstszymi nowotworami pochodzenia mezenchymalnego w obrębie przewodu pokarmowego. Nowotwory te, dzięki postępom w diagnost...